IP Verse

Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient

Patent No. EP2395968 (titled "Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient") was filed by Boehringer Ingelheim on Feb 11, 2010. The application was issued on Jan 17, 2024.

Patent Summary

Pharmaceutical composition comprising a SGLT2 inhibitor as active ingredient, which enables controlled glucose excretion through inhibition of SGLT2-mediated glucose reabsorption in the kidneys. The composition has improved pharmacokinetic properties, including reduced particle size distribution and enhanced bioavailability, making it suitable for oral administration. The formulation enables effective glucose management while maintaining therapeutic efficacy and safety profiles.

Patent Family

Patent Family

Patent Oppositions (19)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRAND MURRAY FULLEROct 17, 2024BRAND MURRAY FULLER
BRAND MURRAY FULLER SERVICESOct 17, 2024BRAND MURRAY FULLER
GENERICS UKOct 17, 2024TER MEER STEINMEISTER & PARTNER
HGFOct 17, 2024HGF
LUIGIOct 17, 2024TER MEER STEINMEISTER & PARTNER
MAIWALDOct 17, 2024MAIWALD
STADA ARZNEIMITTELOct 17, 2024KERNEBECK
ZBM PATENTSOct 17, 2024ZBM PATENTS ZEA
AERAOct 16, 2024AERA
AERAOct 16, 2024BARDEHLE PAGENBERG SL
GALENICUM HEALTH SLUOct 16, 2024GALENICUM HEALTH SLU
HAMM & WITTKOPPOct 16, 2024HAMM & WITTKOPP
KRAUS & LEDERER PARTGMBBOct 16, 2024KRAUS & LEDERER PARTGMBB
TEVA PHARMACEUTICALSOct 16, 2024VON KAUFFMANN
BULLE DROct 15, 2024KUTZENBERGER WOLFF & PARTNER
CAMULONOct 14, 2024REDDIE & GROSE
ZENTIVA KSOct 14, 2024REDDIE & GROSE
POLPHARMAOct 10, 2024ELKINGTON AND FIFE
SANDOZOct 10, 2024ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2395968

BOEHRINGER INGELHEIM
Application Number
EP10703652A
Filing Date
Feb 11, 2010
Status
Granted And Under Opposition
Dec 15, 2023
Publication Date
Jan 17, 2024
External Links
Slate, Register , Google Patents